A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma

BACKGROUND: With the improved knowledge of disease biology and the introduction of immune checkpoints, there has been significant progress in treating renal cell carcinoma (RCC) patients. Individual treatment will differ according to risk stratification. As the clinical course varies in RCC, it has...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chen, Zeng, Hui, Fan, Junli, Huang, Wenjie, Yu, Xiaosi, Li, Shiqi, Wang, Fubing, Long, Xinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918330/
https://www.ncbi.nlm.nih.gov/pubmed/35279104
http://dx.doi.org/10.1186/s12885-022-09322-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918330/
https://www.ncbi.nlm.nih.gov/pubmed/35279104
http://dx.doi.org/10.1186/s12885-022-09322-9

Ejemplares similares